Ep. 69 / Phase 1 Studie: Immuntherapie bei biochemischem Rezidiv des Prostatakarzinoms episode artwork

EPISODE · Aug 1, 2023 · 26 MIN

Ep. 69 / Phase 1 Studie: Immuntherapie bei biochemischem Rezidiv des Prostatakarzinoms

from Leukämie & Tumor Lotse · host Strube-Stiftung

Episode metadata supplied by the publisher feed · Published Aug 1, 2023

Embed this episode

Ready to play

Ep. 69 / Phase 1 Studie: Immuntherapie bei biochemischem Rezidiv des Prostatakarzinoms

0:00 26:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Leukämie & Tumor Lotse?

This episode is 26 minutes long.

When was this Leukämie & Tumor Lotse episode published?

This episode was published on August 1, 2023.

Can I download this Leukämie & Tumor Lotse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!